Yubo International Biotech
(OTC) YBGJ
Yubo International Biotech Financials at a Glance
Market Cap
$2.57M
Revenue (TTM)
$18.00
Net Income (TTM)
$1.23M
EPS (TTM)
$0.00
P/E Ratio
-0.90
Dividend
$0.00
Beta (Volatility)
-0.25 (Low)
Dividend
$0.00
Beta (Volatility)
-0.25 (Low)
Price
$0.02
Volume
20,112
Open
$0.01
Price
$0.02
Volume
20,112
Open
$0.01
Previous Close
$0.02
Daily Range
$0.01 - $0.02
52-Week Range
$0.01 - $0.18
Dividend
$0.00
Beta (Volatility)
-0.25 (Low)
Price
$0.02
Volume
20,112
Open
$0.01
Previous Close
$0.02
Daily Range
$0.01 - $0.02
52-Week Range
$0.01 - $0.18
YBGJ News
YBGJ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Yubo International Biotech
Industry
Biotechnology
Sector
Health CareEmployees
18
CEO
Wang Yang, MBA
Website
www.yubogroup.comHeadquarters
Beijing, CN
YBGJ Financials
Key Financial Metrics (TTM)
Gross Margin
7409%
Operating Margin
76913%
Net Income Margin
68466%
Return on Equity
0%
Return on Capital
86%
Return on Assets
-1%
Earnings Yield
-1.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.57M
Shares Outstanding
170.42M
Volume
20.11K
Short Interest
0.00%
Avg. Volume
4.81K
Financials (TTM)
Gross Profit
$209.28K
Operating Income
$1.77M
EBITDA
$1.80M
Operating Cash Flow
$1.34M
Capital Expenditure
$0.00
Free Cash Flow
$1.34M
Cash & ST Invst.
$7.01K
Total Debt
$478.76K
Yubo International Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$43.59K
-5025.1%
Gross Margin
0.00%
N/A
Market Cap
$2.57M
N/A
Market Cap/Employee
$142.96K
N/A
Employees
18
N/A
Net Income
$276.77K
+24.7%
EBITDA
$266.55K
+23.6%
Quarterly Fundamentals
Net Cash
$127.68K
+77.0%
Accounts Receivable
$398.69K
+21.4%
Inventory
$37.89K
-82.1%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$138.60K
-65.1%
Return on Assets
-1.29%
N/A
Return on Invested Capital
86.41%
N/A
Free Cash Flow
$359.06K
-134.8%
Operating Cash Flow
$359.06K
-134.8%